The founder and billionaire behind Coinbase, an American company that deals with cryptocurrency, is now looking to cure aging and is using machine learning to find it
The founder and billionaire behind Coinbase, an American cryptocurrency company, is now looking to cure aging and is using machine learning to find it.
Brian Armstrong recently announced his new 'epigenetic reprogramming' company, called NewLimit, which aims to make therapies that reverse the aging process.
According to a press release, NewLimit will 'start by deeply interrogating epigenetic drivers of aging and developing products that can regenerate tissues to treat specific patient populations.'
Armstrong plans to employ machine learning to determine what cell features change as we age in order to create 'therapies that could slow, halt, or reverse this process.'
However, NewLimit is still in the concept stage, but Armstrong says the company's founders, Stanford PhD Blake Byers, which includes have committed $105 million to getting it off the ground.
'It is incredibly ambitious to try and 'cure aging' and we believe this mission could take decades to achieve, if it is achievable at all, but that is precisely the reason we feel the urgency to get started today,' Armstrong and Byers shared in a press release.
The key process to NewLimit is uncovering how epigenetic drives ageing, which refers to changes that alter the physical structure of DNA.
Armstrong plans to employ machine learning to determine what cell features change as we age in order to create 'therapies that could slow, halt, or reverse this process'
'NewLimit plans to initially focus on this
